An update on direct antiviral agents for the treatment of hepatitis C-Reference-Cited by-同舟云学术

An update on direct antiviral agents for the treatment of hepatitis C

Published:2021-05-11 Issue:13 Volume:22 Page:1729-1741
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Stanciu Carol¹,Muzica Cristina Maria¹,Girleanu Irina¹,Cojocariu Camelia¹,Sfarti Catalin¹,Singeap Ana-Maria¹,Huiban Laura¹,Chiriac Stefan¹,Cuciureanu Tudor¹,Trifan Anca¹

Affiliation:

1. Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, ST. SpiridonEmergency Hospital, Iasi, Romania

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1921737

Reference88 articles.

1. World Health Organization. Global hepatitis report, 2017. Available from: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1 Cited 2021 Jan 12

2. AASLD. Recommendations for testing, managing, and treating hepatitis C available online at: https://www.hcvguidelines.org/[Accessed on 2021 Jan 12.

3. Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection

4. Hepatitis C Virus Treatment Revolution: Eastern European Story

5. Interferon-Free Hepatitis C Virus Therapy

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection;Cancers;2024-07-18

2. Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population;Journal of Gastrointestinal Cancer;2024-07-08

3. HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination;Viruses;2024-05-30

4. Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy;PLOS ONE;2024-05-23

5. Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?;Cost Effectiveness and Resource Allocation;2024-02-06